MedPath

FDA Clears Foundation Surgical's Vertiwedge® Intraosseous System for Vertebral Body Replacement

• The FDA has granted 510(k) clearance to Foundation Surgical's Vertiwedge® Intraosseous System, a novel device for partial vertebral body replacement in the thoracolumbar spine. • Indicated for use in T1-L5, the device addresses conditions like trauma, fractures, tumors, and degenerative spine disease by restoring vertebral height. • The Vertiwedge® system facilitates vertebral body correction via the VBO® procedure, preserving spinal motion without requiring intervertebral fusion. • As a motion-sparing technique, the device offers effective treatment through a lateral approach, enabling indirect nerve root decompression.

The U.S. Food and Drug Administration (FDA) has cleared Foundation Surgical Group, Inc.'s Vertiwedge® Intraosseous System, a novel spinal vertebral body replacement device. This clearance allows for the partial replacement of a diseased or damaged vertebral body, marking a significant advancement in spine surgery.
The Vertiwedge® Intraosseous System is indicated for use in the thoracolumbar spine (T1-L5). It addresses conditions such as previous trauma (fracture), tumors, or degenerative spine disease. The device is designed to replace a portion and/or restore the height of a collapsed vertebral body following resection or excision.

Innovative Vertebral Body Osteotomy (VBO®) Procedure

According to Foundation Surgical CEO Dr. Randal Betz, the Vertiwedge® clearance and the launch of the VBO® procedure represent "a new era of spine surgery." The VBO® procedure is a novel, single-position, motion-sparing technique that allows for effective treatment through a conventional lateral or oblique lateral approach. This facilitates indirect decompression of the nerve roots while preserving the natural motion of the disc and facet joints, eliminating the need for intervertebral fusion.
The FDA stipulates that the system should be placed within the vertebral body following an osteotomy. It must be supplemented with autograft or allograft and used with its contralateral staple. If fewer than the maximum number of screws are used, supplemental fixation is required to augment stability.

Restoring Spinal Integrity

Foundation Surgical's Vertiwedge® is also intended to restore the integrity of the spinal column, even without fusion, in patients with advanced-stage tumors involving the thoracolumbar spine. This is particularly relevant when the patient's life expectancy is insufficient to permit the achievement of fusion.
The Vertiwedge® obtained 510(k) clearance by demonstrating substantial equivalence to the PILLAR SA PEEK Spacer System, manufactured by Blackstone Medical, Inc. (acquired by Orthofix International NV in 2006).
According to Foundation Surgical, the Vertiwedge® is the first intraosseous device designed to facilitate and maintain vertebral body correction of partially collapsed vertebrae via the VBO® procedure.
Subscribe Icon

Stay Updated with Our Daily Newsletter

Get the latest pharmaceutical insights, research highlights, and industry updates delivered to your inbox every day.

Related Topics

Ventris Medical's Backpack Receives FDA 510(k) Clearance for Orthopedic and Spinal Fusion Procedures

Ventris Medical's Backpack, a porous biologic scaffold, has received FDA 510(k) clearance for orthopedic and spinal fusion applications, enhancing bone formation and cell proliferation.
Backpack AF utilizes a collagen mesh pouch prefilled with osteoinductive Allocell AF allograft fibers, promoting bone remodeling through a 100% biologic graft system.

Merit Medical's WRAPSODY Endoprosthesis Receives FDA Approval for Dialysis Patients

Merit Medical's WRAPSODY Cell-Impermeable Endoprosthesis receives FDA premarket approval, paving the way for its commercial launch in the U.S. in 2025.
The WRAPSODY device is designed to extend long-term vessel patency in dialysis patients by addressing stenosis and thrombosis in arteriovenous (AV) fistulas and grafts.

Acuitive Technologies' Citrepore Receives FDA Clearance for Bone Void Filling

Acuitive Technologies has received FDA 510(k) clearance for Citrepore, a synthetic bioactive bone void filler designed for orthopedic applications.
Citrepore's unique composition promotes natural bone healing by leveraging citrate, a key component in bone metabolism and formation.

R3 Vascular's MAGNITUDE Scaffold Receives FDA Approval for BTK PAD Trial

The FDA has approved R3 Vascular to begin the ELITE-BTK trial for its MAGNITUDE drug-eluting bioresorbable scaffold, targeting below-the-knee peripheral arterial disease.
The MAGNITUDE scaffold, made from ultra-high molecular weight polylactic acid polymer, is designed to gradually absorb into the tissue while providing structural support.

Exactech Receives FDA Clearance for Truliant Porous 3D Tibial Knee Implant

Exactech's Truliant porous 3D tibial tray received FDA 510(k) clearance, marking a significant advancement in cementless knee replacement solutions.
The implant utilizes additive manufacturing to create a porous structure that mimics cancellous bone, promoting initial and biological fixation for active patients.

L&K Biomed's BluEX Lumbar Expandable Cage System Receives FDA Approval

L&K Biomed secured FDA 510(k) clearance for its BluEX Lumbar Expandable Cage System, designed for enhanced bone integration and versatile surgical approaches.
The BluEX system features six cage designs adaptable for anterior, posterior, lateral, ATP, and endoscopic lumbar approaches, offering surgeons greater flexibility.

Catalyst OrthoScience's Shoulder Fracture System Receives FDA Clearance

Catalyst OrthoScience has received FDA 510(k) clearance for its innovative shoulder fracture system, expanding its comprehensive orthopedic portfolio.
The Catalyst fracture system is specifically designed for reverse shoulder arthroplasty in patients suffering from proximal humerus fractures.

SpineGuard's PsiFGuard Receives FDA Clearance for Sacroiliac Joint Fusion

SpineGuard's PsiFGuard, a smart drilling device for posterior sacroiliac fusion (PsiF), has received FDA 510(k) clearance for commercial use in the United States.
The PsiFGuard device utilizes SpineGuard's Dynamic Surgical Guidance (DSG®) technology to enhance the accuracy of implant placement in SI joint fusion procedures.

FDA Expands Indications for Cerapedics' i-FACTOR Bone Graft in Cervical Spinal Fusion

The FDA has approved expanded indications for Cerapedics' i-FACTOR P-15 Peptide Enhanced Bone Graft, enhancing its utility in spinal fusion procedures.
i-FACTOR is now approved for single-level ACDF with an allograft bone ring or with PEEK or titanium interbody devices, alongside anterior plate fixation.

FDA Approves Clinical Trial for PEEK-OPTIMA Knee Implant

The FDA has granted Investigational Device Exemption (IDE) approval for the Freedom® Total Knee System with Invibio PEEK-OPTIMA™ Femoral Component.
A study involving 120 patients across US clinical sites will compare the PEEK-OPTIMA™ component against traditional metal components in total knee arthroplasty.

Reference News

[1]
FDA Clears Dr. Betz's Vertebral Body Replacement Device | Orthopedics This Week
ryortho.com · Nov 29, 2024

FDA grants 510(k) clearance to Vertiwedge® Intraosseous System for partial vertebral body replacement in thoracolumbar s...

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy